Bodour Saeed Rajab
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Bodour Saeed Rajab has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Abdelhakim Bouyahya
Laboratory of Human Pathologies Biology, Faculty of Sciences, Mohammed V University in Rabat, Rabat, Morocco
6 shared publications - Hamza Assaggaf
Clinical Laboratory Sciences Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, Saudi Arabia
6 shared publications - Hanae Naceiri Mrabti
High Institute of Nursing Professions and Health Techniques Casablanca, Casablanca 20250, Morocco
6 shared publications - Ahmed Qasem
Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah, 21955, Saudi Arabia
3 shared publications - Ammar A. Attar
Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah 21955, Saudi Arabia
3 shared publications - Anmar Anwar Khan
Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah 21955, Saudi Arabia
3 shared publications
Latest Publications
- Open Access
Edaravone Improves the Efficacy of Metformin Against Diabetic Nephropathy by Attenuating Inflammation, Oxidative Stress, and Apoptosis with Associated Modulation of MAPK/NF-κB1 and AKT/NRF2 Pathways in Rats
The present study investigated the protective effects of edaravone (EDA), metformin (Met), and their combined treatment against diabetic nephropathy (DN) in rats. Sixteen normal non-diabetic rats were allocated to the negative control (NC) and EDA-treated control (EDA10; 10 mg/kg/day) groups and received a standard diet throughout the study. Type 2 diabetes was induced by feeding male Wistar rats (n = 40) a high-fat diet (HFD) for four weeks followed by a single intraperitoneal injection of streptozotocin (STZ; 40 mg/kg). Of the 40 rats, 36 developed diabetes; 32 were subsequently maintained on the HFD for an additional four weeks to establish DN and were then randomly allocated into four equal diabetic groups (n = 8/group) for the 8-week therapeutic intervention as follows: untreated DN, DN treated with Met alone (300 mg/kg/day), and DN treated with Met combined with either 5 or 10 mg/kg/day EDA. The diabetic animals remained on the HFD throughout the intervention period. Blood, urine, and renal tissue were collected to assess glucose homeostasis along with renal function, histopathology, oxidative stress, antioxidant defense, inflammation, apoptosis, and selected molecular regulatory markers at both gene and protein levels. DN was associated with impaired glucose homeostasis together with marked renal dysfunction, histopathological injury, oxidative stress, inflammation, and apoptosis. While Met significantly ameliorated many of these abnormalities, co-administration of EDA produced additional improvements, with the greatest overall effects observed with the higher EDA dose. Correlation and Mantel network analyses showed stronger associations of Mapk1 expression with renal injury, inflammation, and oxidative stress markers in DN, whereas combined treatment was associated with stronger relationships between Akt1 and Hmox1 expression and the cytoprotective biomarkers. In conclusion, combined EDA and Met treatment produced greater overall renoprotective effects than Met monotherapy, with the higher EDA dose showing the strongest nephroprotection. Further studies are required to determine the mechanisms underlying EDA-associated renoprotection and their translational relevance in humans.
Open AccessEdaravone Improves the Efficacy of Metformin Against Diabetic Nephropathy by Attenuating Inflammation, Oxidative Stress, and Apoptosis with Associated Modulation of MAPK/NF-κB1 and AKT/NRF2 Pathways in Rats
The present study investigated the protective effects of edaravone (EDA), metformin (Met), and their combined treatment against diabetic nephropathy (DN) in rats. Sixteen normal non-diabetic rats were allocated to the negative control (NC) and EDA-treated control (EDA10; 10 mg/kg/day) groups and received a standard diet throughout the study. Type 2 diabetes was induced by feeding male Wistar rats (n = 40) a high-fat diet (HFD) for four weeks followed by a single intraperitoneal injection of streptozotocin (STZ; 40 mg/kg). Of the 40 rats, 36 developed diabetes; 32 were subsequently maintained on the HFD for an additional four weeks to establish DN and were then randomly allocated into four equal diabetic groups (n = 8/group) for the 8-week therapeutic intervention as follows: untreated DN, DN treated with Met alone (300 mg/kg/day), and DN treated with Met combined with either 5 or 10 mg/kg/day EDA. The diabetic animals remained on the HFD throughout the intervention period. Blood, urine, and renal tissue were collected to assess glucose homeostasis along with renal function, histopathology, oxidative stress, antioxidant defense, inflammation, apoptosis, and selected molecular regulatory markers at both gene and protein levels. DN was associated with impaired glucose homeostasis together with marked renal dysfunction, histopathological injury, oxidative stress, inflammation, and apoptosis. While Met significantly ameliorated many of these abnormalities, co-administration of EDA produced additional improvements, with the greatest overall effects observed with the higher EDA dose. Correlation and Mantel network analyses showed stronger associations of Mapk1 expression with renal injury, inflammation, and oxidative stress markers in DN, whereas combined treatment was associated with stronger relationships between Akt1 and Hmox1 expression and the cytoprotective biomarkers. In conclusion, combined EDA and Met treatment produced greater overall renoprotective effects than Met monotherapy, with the higher EDA dose showing the strongest nephroprotection. Further studies are required to determine the mechanisms underlying EDA-associated renoprotection and their translational relevance in humans.
- 30 May 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (21)
Computational Evaluation of AMPK‐Activating Phytochemical Analogues Targeting Metabolic Memory in Type 2 Diabetes
Metabolic Memory (MM) is a major contributor to the long‐term complications of type 2 Diabetes Mellitus (T2DM). This study aimed to identify natural activators of AMP‐activated protein kinase (AMPK), a central energy regulator with multiple downstream signaling roles implicated in MM by targeting its two allosteric sites to counteract MM‐associated diabetic complications. An integrative in silico and network‐pharmacology approach was employed. Several well‐established AMPK‐activating phytochemicals and approximately 50 structural analogs screened with two allosteric sites (sites 1; α‐β subunit and site 2; γ subunit) of AMPK, via molecular docking. Docking results identified four top‐scoring phytochemicals among 46 compound, coptisine (‐9.2 kcal/mol) and glabrene (‐10.3 kcal/mol) targeting the α‐β site, alongside luteolin (‐9.3 kcal/mol) and dihydromyricetin (‐10 kcal/mol) targeting γ site. The top‐scoring complexes were subjected to 100 ns molecular dynamics (MD) simulations which confirmed the overall stability of all four phytochemicals along with their respective standards. ADMET profiling shows pharmacokinetic properties expect dihydromyricetin, violated Lipinski's rule of 5, and Network pharmacology (probability confidence score more than 60%) mapped relevant disease pathways involvement of AGE‐RAGE and AMPK signaling pathways in mediating the therapeutic potential of these compounds. These findings provide a strong foundation for future experimental validation and the therapeutic development of MM‐targeted interventions.
- 30 May 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (21)
Computational Evaluation of AMPK‐Activating Phytochemical Analogues Targeting Metabolic Memory in Type 2 Diabetes
Metabolic Memory (MM) is a major contributor to the long‐term complications of type 2 Diabetes Mellitus (T2DM). This study aimed to identify natural activators of AMP‐activated protein kinase (AMPK), a central energy regulator with multiple downstream signaling roles implicated in MM by targeting its two allosteric sites to counteract MM‐associated diabetic complications. An integrative in silico and network‐pharmacology approach was employed. Several well‐established AMPK‐activating phytochemicals and approximately 50 structural analogs screened with two allosteric sites (sites 1; α‐β subunit and site 2; γ subunit) of AMPK, via molecular docking. Docking results identified four top‐scoring phytochemicals among 46 compound, coptisine (‐9.2 kcal/mol) and glabrene (‐10.3 kcal/mol) targeting the α‐β site, alongside luteolin (‐9.3 kcal/mol) and dihydromyricetin (‐10 kcal/mol) targeting γ site. The top‐scoring complexes were subjected to 100 ns molecular dynamics (MD) simulations which confirmed the overall stability of all four phytochemicals along with their respective standards. ADMET profiling shows pharmacokinetic properties expect dihydromyricetin, violated Lipinski's rule of 5, and Network pharmacology (probability confidence score more than 60%) mapped relevant disease pathways involvement of AGE‐RAGE and AMPK signaling pathways in mediating the therapeutic potential of these compounds. These findings provide a strong foundation for future experimental validation and the therapeutic development of MM‐targeted interventions.
- Open Access
- 19 May 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (10) , 1545
Machine Learning Applications for Risk Stratification in Heart Failure with Preserved Ejection Fraction: A New Era in Cardiology
Heart failure with preserved ejection fraction (HFpEF) is a prevalent and heterogeneous syndrome with limited therapeutic options, making accurate risk stratification essential yet challenging. Traditional tools such as the H2FPEF and HFA-PEFF scores incorporate few variables and demonstrate modest prognostic performance. Machine learning (ML) offers enhanced risk prediction by integrating multidimensional clinical, imaging, biomarker, and molecular data. This review summarizes current ML applications in HFpEF, including random forests, gradient boosting, support vector machines, and deep learning, highlighting their superior discrimination and ability to reveal phenotypic subgroups with distinct outcomes. We also address practical considerations such as interpretability, real-world validation, and integration into clinical workflows, as well as challenges related to data bias, generalizability, and regulatory requirements. Future opportunities include real-time clinical decision support, digital health integration, and interventional ML to guide personalized therapy. ML holds significant potential to advance precision care and improve outcomes in HFpEF.
- 19 May 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (10) , 1545
Open AccessMachine Learning Applications for Risk Stratification in Heart Failure with Preserved Ejection Fraction: A New Era in Cardiology
Heart failure with preserved ejection fraction (HFpEF) is a prevalent and heterogeneous syndrome with limited therapeutic options, making accurate risk stratification essential yet challenging. Traditional tools such as the H2FPEF and HFA-PEFF scores incorporate few variables and demonstrate modest prognostic performance. Machine learning (ML) offers enhanced risk prediction by integrating multidimensional clinical, imaging, biomarker, and molecular data. This review summarizes current ML applications in HFpEF, including random forests, gradient boosting, support vector machines, and deep learning, highlighting their superior discrimination and ability to reveal phenotypic subgroups with distinct outcomes. We also address practical considerations such as interpretability, real-world validation, and integration into clinical workflows, as well as challenges related to data bias, generalizability, and regulatory requirements. Future opportunities include real-time clinical decision support, digital health integration, and interventional ML to guide personalized therapy. ML holds significant potential to advance precision care and improve outcomes in HFpEF.
- Open Access
- 31 March 2023
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 26 (1) , 27-37
Phytochemical, Antidiabetic, Antioxidant, Antibacterial, Acute and Sub-Chronic Toxicity of Moroccan Arbutus unedo Leaves
Latifa Doudach, Hanae Naceiri Mrabti, Samiah Hamad Al-Mijalli, Mohamed Reda Kachmar, Kaoutar Benrahou, Hamza Assaggaf, Ahmed Qasem, Emad Mohamed Abdallah, Bodour Saeed Rajab, Khouloud Harraqui, Mouna Mekkaoui, Abdelhakim Bouyahya, Moulay El Abbes Faouzi. J Pharmacopuncture 2023;26:27-37. https://doi.org/10.3831/KPI.2023.26.1.27
- 31 March 2023
- Published by Korean Pharmacopuncture Institute in Journal of Pharmacopuncture
- Vol. 26 (1) , 27-37
Open AccessPhytochemical, Antidiabetic, Antioxidant, Antibacterial, Acute and Sub-Chronic Toxicity of Moroccan Arbutus unedo Leaves
Latifa Doudach, Hanae Naceiri Mrabti, Samiah Hamad Al-Mijalli, Mohamed Reda Kachmar, Kaoutar Benrahou, Hamza Assaggaf, Ahmed Qasem, Emad Mohamed Abdallah, Bodour Saeed Rajab, Khouloud Harraqui, Mouna Mekkaoui, Abdelhakim Bouyahya, Moulay El Abbes Faouzi. J Pharmacopuncture 2023;26:27-37. https://doi.org/10.3831/KPI.2023.26.1.27
- Open Access
Determination of Chemical Composition and Investigation of Biological Activities of Ocimum basilicum L.
This study aimed to determine the chemical composition of the essential oils (EOs) of Ocimum basilicum L., as well as to evaluate the antibacterial, antidiabetic, dermatoprotective, and anti-inflammatory properties, and the EOs and aqueous extracts of O. basilicum. The antibacterial activity was evaluated against bacterial strains, Gram-positive and Gram-negative, using the well diffusion and microdilution methods, whereas the antidiabetic activity was assessed in vitro using two enzymes involved in carbohydrate digestion, α-amylase and α-glucosidase. On the other hand, the dermatoprotective and anti-inflammatory activities were studied by testing tyrosinase and lipoxygenase inhibition activity, respectively. The results showed that the chemical composition of O. basilicum EO (OBEO) is dominated by methyl chavicol (86%) and trans-anethol (8%). OBEO exhibited significant antibacterial effects against Gram-negative and Gram-positive strains, demonstrated by considerable diameters of the inhibition zones and lower MIC and MBC values. In addition, OBEO exhibited significant inhibition of α-amylase (IC50 = 50.51 ± 0.32 μg/mL) and α-glucosidase (IC50 = 39.84 ± 1.2 μg/mL). Concerning the anti-inflammatory activity, OBEO significantly inhibited lipoxygenase activity (IC50 = 18.28 ± 0.03 μg/mL) compared to the aqueous extract (IC50 = 24.8 ± 0.01 μg/mL). Moreover, tyrosinase was considerably inhibited by OBEO (IC50 = 68.58 ± 0.03 μg/mL) compared to the aqueous extract (IC50 = 118.37 ± 0.05 μg/mL). The toxicological investigations revealed the safety of O. basilicum in acute and chronic toxicity. The finding of in silico analysis showed that methyl chavicol and trans-anethole (main compounds of OBEO) validate the pharmacokinetics of these compounds and decipher some antibacterial targets.
Open AccessDetermination of Chemical Composition and Investigation of Biological Activities of Ocimum basilicum L.
This study aimed to determine the chemical composition of the essential oils (EOs) of Ocimum basilicum L., as well as to evaluate the antibacterial, antidiabetic, dermatoprotective, and anti-inflammatory properties, and the EOs and aqueous extracts of O. basilicum. The antibacterial activity was evaluated against bacterial strains, Gram-positive and Gram-negative, using the well diffusion and microdilution methods, whereas the antidiabetic activity was assessed in vitro using two enzymes involved in carbohydrate digestion, α-amylase and α-glucosidase. On the other hand, the dermatoprotective and anti-inflammatory activities were studied by testing tyrosinase and lipoxygenase inhibition activity, respectively. The results showed that the chemical composition of O. basilicum EO (OBEO) is dominated by methyl chavicol (86%) and trans-anethol (8%). OBEO exhibited significant antibacterial effects against Gram-negative and Gram-positive strains, demonstrated by considerable diameters of the inhibition zones and lower MIC and MBC values. In addition, OBEO exhibited significant inhibition of α-amylase (IC50 = 50.51 ± 0.32 μg/mL) and α-glucosidase (IC50 = 39.84 ± 1.2 μg/mL). Concerning the anti-inflammatory activity, OBEO significantly inhibited lipoxygenase activity (IC50 = 18.28 ± 0.03 μg/mL) compared to the aqueous extract (IC50 = 24.8 ± 0.01 μg/mL). Moreover, tyrosinase was considerably inhibited by OBEO (IC50 = 68.58 ± 0.03 μg/mL) compared to the aqueous extract (IC50 = 118.37 ± 0.05 μg/mL). The toxicological investigations revealed the safety of O. basilicum in acute and chronic toxicity. The finding of in silico analysis showed that methyl chavicol and trans-anethole (main compounds of OBEO) validate the pharmacokinetics of these compounds and decipher some antibacterial targets.
- Open Access
- 26 August 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 4212331
Antioxidative and Anti‐Inflammatory Protective Effects of β‐Caryophyllene against Amikacin‐Induced Nephrotoxicity in Rat by Regulating the Nrf2/AMPK/AKT and NF‐κB/TGF‐β/KIM‐1 Molecular Pathways
Herein, the molecular pathogenic pathways implicated in renal injury triggered by amikacin (AK), together with the alleviating actions of β‐caryophyllene (BCP), were investigated. Adult male Wistar rats (n = 32) were disseminated to the four following groups (n = 8/group): normal group, positive control animals (PC) that received AK intraperitoneal injections for 14 days (500 mg/kg/day), and rats that received AK simultaneously with small (200 mg/kg/day) and high doses (400 mg/kg/day) of BCP. The PC renal tissues revealed abnormal histology alongside increased apoptosis and significantly elevated serum creatinine and urea with marked proteinuria and oliguria relative to the normal rats. Moreover, renal tissues from the PC animals also showed substantial upregulations in NF‐κB/TGF‐β/KIM‐1, whilst Nrf2/AMPK/AKT/PCNA declined, at the gene and protein levels in comparison to the normal rats. Additionally, the levels of markers of oxidative stress (MDA/H2O2/protein adducts) and inflammation (TNF‐α/IL‐1β/IL‐6/IL‐18/TLR/HSP25) were substantially higher in the PC renal specimens, whereas the antioxidants (GSH/GPx/SOD1/CAT) and interleukin‐10 decreased, relative to the NC group. Both BCP protocols improved the biochemical markers of renal functions, alleviated renal histopathology and apoptosis, and decreased NF‐κB/TGF‐β/KIM‐1 alongside the concentrations of oxidative stress and proinflammatory markers, whilst promoting Nrf2/AMPK/AKT/IL‐10/PCNA and the targeted antioxidants. However, the improving effects in the high‐dose regimen were markedly stronger than those observed in animals treated with low dose of BCP. In conclusion, the present report is the first to connect NF‐κB/TGF‐β/KIM‐1 proinflammatory and Nrf2/AMPK/AKT antioxidative stress pathways with the pathogenesis of AK‐induced nephrotoxicity. Additionally, the current report is the first to disclose alleviating activities for BCP against AK‐triggered nephrotoxicity by modulating multiple antioxidative stress with anti‐inflammatory molecular pathways.
- 26 August 2022
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 4212331
Open AccessAntioxidative and Anti‐Inflammatory Protective Effects of β‐Caryophyllene against Amikacin‐Induced Nephrotoxicity in Rat by Regulating the Nrf2/AMPK/AKT and NF‐κB/TGF‐β/KIM‐1 Molecular Pathways
Herein, the molecular pathogenic pathways implicated in renal injury triggered by amikacin (AK), together with the alleviating actions of β‐caryophyllene (BCP), were investigated. Adult male Wistar rats (n = 32) were disseminated to the four following groups (n = 8/group): normal group, positive control animals (PC) that received AK intraperitoneal injections for 14 days (500 mg/kg/day), and rats that received AK simultaneously with small (200 mg/kg/day) and high doses (400 mg/kg/day) of BCP. The PC renal tissues revealed abnormal histology alongside increased apoptosis and significantly elevated serum creatinine and urea with marked proteinuria and oliguria relative to the normal rats. Moreover, renal tissues from the PC animals also showed substantial upregulations in NF‐κB/TGF‐β/KIM‐1, whilst Nrf2/AMPK/AKT/PCNA declined, at the gene and protein levels in comparison to the normal rats. Additionally, the levels of markers of oxidative stress (MDA/H2O2/protein adducts) and inflammation (TNF‐α/IL‐1β/IL‐6/IL‐18/TLR/HSP25) were substantially higher in the PC renal specimens, whereas the antioxidants (GSH/GPx/SOD1/CAT) and interleukin‐10 decreased, relative to the NC group. Both BCP protocols improved the biochemical markers of renal functions, alleviated renal histopathology and apoptosis, and decreased NF‐κB/TGF‐β/KIM‐1 alongside the concentrations of oxidative stress and proinflammatory markers, whilst promoting Nrf2/AMPK/AKT/IL‐10/PCNA and the targeted antioxidants. However, the improving effects in the high‐dose regimen were markedly stronger than those observed in animals treated with low dose of BCP. In conclusion, the present report is the first to connect NF‐κB/TGF‐β/KIM‐1 proinflammatory and Nrf2/AMPK/AKT antioxidative stress pathways with the pathogenesis of AK‐induced nephrotoxicity. Additionally, the current report is the first to disclose alleviating activities for BCP against AK‐triggered nephrotoxicity by modulating multiple antioxidative stress with anti‐inflammatory molecular pathways.
- Open Access
Chemical Analysis and Investigation of Biological Effects of Salvia officinalis Essential Oils at Three Phenological Stages
Salvia officinalis is a medicinal plant used to treat some diseases, including microbial infections and diabetes. Different studies showed the biological and pharmacological properties of this species. The aim of this study was the determination of the chemical compounds of S. officinalis essential oils and the investigation of their antimicrobial, antioxidant, antidiabetic, and anti-inflammatory properties. The chemical compounds of S. officinalis were determined by GC-MS analysis. The antioxidant activity was assessed by DPPH, ABTS, H2O2, and FRAP assays. The in vitro antidiabetic effect was evaluated by the inhibition of α-amylase, α-glucosidase, and lipase activities, and the anti-inflammatory effect was evaluated using the 5-lipoxygenase assay. Moreover, antibacterial activity was assessed against six bacterial strains using agar well diffusion assay and microdilution method. The main compounds in essential oils of S. officinalis at three phenological stages were naphthalenone, camphor, 1.8-cineole, and α-thujone. The full flowering stage essential oil showed the best antioxidant activity with different IC50 values according to the used tests. This oil also exhibited important inhibitory effects at the full flowering stage against α-amylase (IC50 = 69.23 ± 0.1 μg/mL), α-glucosidase (IC50 = 22.24 ± 0.07 μg/mL), and lipase (IC50 = 37.3 ± 0.03 μg/mL). The 5-lipoxygenase inhibitory effect was the best at the full flowering stage (IC50 = 9.24 ± 0.03 μg/mL). The results of the antibacterial evaluation revealed that, at three seasonal periods, S. officinalis essential oil demonstrated strong antibacterial activity. Although the full flowering stage had the best antibacterial activity, there were no significant differences between the three stages. Additionally, the essential oils showed bactericidal effects on Listeria monocytogenes, Staphylococcus aureus, Bacillus subtilis, Proteus mirabilis, Escherichia coli, and Salmonella typhimurium, respectively. The findings of this work showed remarkably that S. officinalis synthesizes essential oils according to different developmental stages. Moreover, it has exhibited interesting biological and pharmacological properties justifying its medicinal effects and suggesting it as a very important source of natural drugs.
Open AccessChemical Analysis and Investigation of Biological Effects of Salvia officinalis Essential Oils at Three Phenological Stages
Salvia officinalis is a medicinal plant used to treat some diseases, including microbial infections and diabetes. Different studies showed the biological and pharmacological properties of this species. The aim of this study was the determination of the chemical compounds of S. officinalis essential oils and the investigation of their antimicrobial, antioxidant, antidiabetic, and anti-inflammatory properties. The chemical compounds of S. officinalis were determined by GC-MS analysis. The antioxidant activity was assessed by DPPH, ABTS, H2O2, and FRAP assays. The in vitro antidiabetic effect was evaluated by the inhibition of α-amylase, α-glucosidase, and lipase activities, and the anti-inflammatory effect was evaluated using the 5-lipoxygenase assay. Moreover, antibacterial activity was assessed against six bacterial strains using agar well diffusion assay and microdilution method. The main compounds in essential oils of S. officinalis at three phenological stages were naphthalenone, camphor, 1.8-cineole, and α-thujone. The full flowering stage essential oil showed the best antioxidant activity with different IC50 values according to the used tests. This oil also exhibited important inhibitory effects at the full flowering stage against α-amylase (IC50 = 69.23 ± 0.1 μg/mL), α-glucosidase (IC50 = 22.24 ± 0.07 μg/mL), and lipase (IC50 = 37.3 ± 0.03 μg/mL). The 5-lipoxygenase inhibitory effect was the best at the full flowering stage (IC50 = 9.24 ± 0.03 μg/mL). The results of the antibacterial evaluation revealed that, at three seasonal periods, S. officinalis essential oil demonstrated strong antibacterial activity. Although the full flowering stage had the best antibacterial activity, there were no significant differences between the three stages. Additionally, the essential oils showed bactericidal effects on Listeria monocytogenes, Staphylococcus aureus, Bacillus subtilis, Proteus mirabilis, Escherichia coli, and Salmonella typhimurium, respectively. The findings of this work showed remarkably that S. officinalis synthesizes essential oils according to different developmental stages. Moreover, it has exhibited interesting biological and pharmacological properties justifying its medicinal effects and suggesting it as a very important source of natural drugs.
- Open Access
- 11 August 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-13
Effects of Resveratrol Against Induced Metabolic Syndrome in Rats: Role of Oxidative Stress, Inflammation, and Insulin Resistance
Metabolic syndrome (MS) is a serious health problem associated with an increase in risk factors for hepatic steatosis, which is the most common liver disease today. The goal of this study was to investigate the protective effects of resveratrol against metabolic alterations associated with a high-fat high-fructose diet (HFFD). Thirty-two male rats were randomly divided into four equal groups: control (cont.), metabolic syndrome (MS), resveratrol (Res), and metabolic syndrome treated with resveratrol (MS+Res). Resveratrol was administrated orally at a dose of 30mg/kg·bw, daily. After 10weeks, body weight, serum biochemical parameters, hepatic oxidative stress, inflammatory markers, as well as mRNA levels of hepatic genes related to lipid metabolism and insulin signaling were measured. In addition, the liver was examined histopathologically to detect lipid deposition. Increased body weight, hepatic dysfunction, dyslipidemia, hepatic insulin resistance, hepatic oxidative and inflammatory stress conditions, upregulation of mRNA expression level of sterol regulatory element binding protein 1-c (SREBP1-c), and downregulation of mRNA expression levels of peroxisome proliferated activated receptor alpha (PPARα) and insulin receptor substrate-2 (IR-S2) were all observed in the MS rats. Hepatic steatosis was confirmed by hematoxylin and eosin and Oil Red O staining. Administration of resveratrol reduced liver steatosis, oxidative stress, and inflammatory state. Also, it improved lipid profile as well as insulin sensitivity and reverted alterations in hepatic mRNA expression levels of the tested genes. Based on these findings, resveratrol could be proposed as a therapeutic approach for MS prevention.
- 11 August 2022
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2022, 1-13
Open AccessEffects of Resveratrol Against Induced Metabolic Syndrome in Rats: Role of Oxidative Stress, Inflammation, and Insulin Resistance
Metabolic syndrome (MS) is a serious health problem associated with an increase in risk factors for hepatic steatosis, which is the most common liver disease today. The goal of this study was to investigate the protective effects of resveratrol against metabolic alterations associated with a high-fat high-fructose diet (HFFD). Thirty-two male rats were randomly divided into four equal groups: control (cont.), metabolic syndrome (MS), resveratrol (Res), and metabolic syndrome treated with resveratrol (MS+Res). Resveratrol was administrated orally at a dose of 30mg/kg·bw, daily. After 10weeks, body weight, serum biochemical parameters, hepatic oxidative stress, inflammatory markers, as well as mRNA levels of hepatic genes related to lipid metabolism and insulin signaling were measured. In addition, the liver was examined histopathologically to detect lipid deposition. Increased body weight, hepatic dysfunction, dyslipidemia, hepatic insulin resistance, hepatic oxidative and inflammatory stress conditions, upregulation of mRNA expression level of sterol regulatory element binding protein 1-c (SREBP1-c), and downregulation of mRNA expression levels of peroxisome proliferated activated receptor alpha (PPARα) and insulin receptor substrate-2 (IR-S2) were all observed in the MS rats. Hepatic steatosis was confirmed by hematoxylin and eosin and Oil Red O staining. Administration of resveratrol reduced liver steatosis, oxidative stress, and inflammatory state. Also, it improved lipid profile as well as insulin sensitivity and reverted alterations in hepatic mRNA expression levels of the tested genes. Based on these findings, resveratrol could be proposed as a therapeutic approach for MS prevention.